Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Kenneth Marek
Based on 54 articles published since 2008
||||
Expertise Level
The expertise of Kenneth Marek ranks in the
  • Top 0.4%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 54 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Marek, Ken   ·   Marek, K   ·   Marek, Kenneth
Work Locations
Details
Most likely:    Miscellaneous institutions in New Haven      
2018
  • Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA. · University of Pennsylvania School of Medicine and the Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel, University Medical Center Goettingen, Kassel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of California San Francisco, San Francisco, California, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of Rochester Medical Center, Rochester, New York, USA. · University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · Pubmed 28986467
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • a Parkinson's Disease and Movement Disorders Center of Boca Raton , FL , USA. · b Saint Luke's Marion Bloch Neuroscience Institute , Kansas City , MO , USA. · c Hackensack University Medical Center, Movement Disorders Center , Hackensack , NJ , USA. · d Irvine Health Movement Disorders Program , University of California , Irvine , CA , USA. · e Thomas Jefferson University, Sidney Kimmel Medical College , Philadelphia , PA , USA. · f University of Southern California Keck School of Medicine , Los Angeles , CA , USA. · g Institute for Neurodegenerative Disorders , New Haven , CT , USA. · h University of Kansas Medical Center , Kansas City , KS , USA. · Pubmed 27813429
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Pubmed 29114721
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 29063713
  • From the Department of Neurology (B.M.), University Medical Center, Göttingen · Paracelsus-Elena-Klinik (B.M.), Kassel, Germany · Department of Biostatistics (C.J.C.-G., C.S.C.), College of Public Health, University of Iowa, Iowa City · BioLegend Inc. (P.T.), San Diego, CA · Department of Pathology & Laboratory Medicine (L.M.S., J.Q.T.), Center for Neurodegenerative Disease Research, Institute on Aging (L.M.S. , J.Q.T.), and Morris K. Udall Center of Excellence for Parkinson's Disease Research (J.Q.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia · Molecular Genetics Section (A.S.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD · The Michael J. Fox Foundation for Parkinson's Research (M.F.), New York, NY · Institute for Neurodegenerative Disorders (K.M.), New Haven, CT · and Department of Neurosciences (D.G.), University of California, San Diego. · Pubmed 29030452
  • Parkinson's Disease Research, Education, and Clinical Center (PADRECC), Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Parkinson's Associated Risk Study, New Haven, Connecticut, USA. · Eli Lilly and Company, New York, New York, USA. · Pubmed 28906025
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA; Department of Neurology, Oregon Health & Science University, Portland, USA. · Biomedical Signal Processing Laboratory, Portland State University, Portland, OR, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Eli Lilly and Company, New York, NY, USA. · Pubmed 28747279
  • GNS Healthcare, Cambridge, Massachusetts, United States of America. · Novartis, Cambridge, Massachusetts, United States of America. · Alexion Pharmaceuticals, Cambridge, Massachusetts, United States of America. · University of Rochester, Rochester, New York, United States of America. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States of America. · Georgetown University, Washington, DC, United States of America. · National Institute on Aging, NIH, Bethesda, Maryland, United States of America. · University of San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America. · Biogen Idec, Cambridge, Massachusetts, United States of America. · Voyager Therapeutics, Cambridge, Massachusetts, United States of America. · Pubmed 28604798
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York. · Pubmed 28595287
  • Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Neurology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, The University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain. · Department of Neurology, Hephata-Klinik, Hephata Hessisches Diakoniezentrum, e.V., Schwalmstadt-Treysa, Germany. · Cleveland Clinic Neurological Institute, Cleveland, Ohio, USA. · Division of Neurology, McGill University, Montreal, Québec, Canada. · Department of Neurology, Philipps University, Marburg, Germany. · Charitable Hertie Foundation, Frankfurt, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28554959
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, People's Republic of China. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 27666574
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Catalonia, Spain. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · BioLegend Inc, Dedham, Massachusetts, USA. · Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Department of Neurology, St. Olav's Hospital, Trondheim, Norway. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada. · Biostatistics and Data Management Core Facility, IDIBAPS (Hospital Clinic), Barcelona, Spain. · Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Centro en Red para la Investigación de Enfermedades Neurodegenerativas CIBERNED, Spain. · Pubmed 27041685
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Department of Pharmacology, Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Republic of Korea. · Paracelsus-Elena Klinik, Kassel, Germany. · Department of Neuropathology and Neurosurgery, University Medical Center Goettingen, Göttingen, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Veterans Affairs, Philadelphia, PA, USA. · Department of Neurosciences, University of California, San Diego, CA, USA. · BioLegend Inc., Dedham, MA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · University of California-San Francisco and San Francisco Veteran's Affairs Medical Center, San Francisco, CA, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Laboratory of Neuro Imaging, The Institute for Neuroimaging and Informatics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 27021906
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, University of Rochester School of Medicine, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 26293177
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2015
  • Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, China. · Hopital De La Salpetriere, Paris, France. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-FIMA, Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474317
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · University of Navarra-FIMA, Pamplona, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474316
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Veteran Affairs Medical Center, San Francisco, California, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular Neuroimaging, LLC (MNI), New Haven, Connecticut, USA. · Baylor College of Medicine, Houston, Texas, USA. · Department of Neurology, University of California, San Francisco, CA, USA. · Emory University, Atlanta, Georgia, USA. · University of Tuebingen, Tuebingen, Germany. · Innsbruck Medical University, Innsbruck, Austria. · Paracelsus-Elena Klinik, Kassel, Germany. · Johns Hopkins University, Baltimore, Maryland, USA. · Macquarie University, Sydney, Australia. · Pubmed 26260437
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · The University of Iowa, Iowa City, IA, USA. · The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Charitable Hertie Foundation, Frankfurt/Main, Germany. · Hephata-Klinik, Hephata Hessisches Diakoniezentrum e. V. · Innsbruck Medical University, Innsbruck, Austria. · McGill University, Montréal, Québec, Canada. · Massachusetts General Hospital, Boston, MA, USA. · UAB School of Medicine, Birmingham, AL, USA. · Pubmed 26095202
2014
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA. · Program for Regulatory Science & Medicine (PRSM), Georgetown University, Washington, D.C., USA. · Pubmed 25062961
  • From the Institute for Neurodegenerative Disorders (D.J., J.S., K.M.), New Haven, CT · Parkinson's Disease and Movement Disorders Center (M.S.), Department of Neurology, University of Pennsylvania, Philadelphia · Department of Biostatistics and Computational Biology (S.E., D.O.), University of Rochester, NY · and Avid Radiopharmaceuticals (A.S.), Philadelphia, PA. · Pubmed 25298306
2009
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 19221310
2008
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 19127587
2012
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 23026362
  • Institute for Neurodegenerative Disorders, Molecular NeuroImaging, LLC, New Haven, Connecticut 06510, USA. · Pubmed 22460156
Probable:    Yale University   Contact    
2017
  • Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Department of Biostatistics, University of Iowa, 145 N. Riverside Drive, 100 CPHB, Iowa City, Iowa, 52242, USA. · BioLegend, Inc., 180 Rustcraft Rd # 140, Dedham, Massachusetts, 02026, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Kassel, Germany. · Georg-August University Medical Center Goettingen, 37075, Goettingen, Germany. · Program in Neuroscience and Division of Neurology, The Ottawa Hospital, University of Ottawa Brain & Mind Institute, 451 Smyth Road, Room 1412, Ottawa, K1H 8M5, Canada. · Follow the Molecule, 143 Voyage Mall, Marina del Rey, CA, 90292, USA. · PAREXEL International, Early Phase Unit, 1560 E. Chevy Chase Drive, Suite 140, Glendale, CA, 91206, USA. · Research Programs, The Michael J. Fox Foundation for Parkinson's Research, 69 7th Avenue, 498, New York, NY, 10018, USA. · Yale-New Haven Hospital, 20 York Street, New Haven, CT, 06510, USA. · Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. · Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Pubmed 28821274
2012
  • Yale University School of Medicine, New Haven, Connecticut 06519, USA. · Pubmed 22609082
Probable:    Miscellaneous institutions in Tubingen      
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2014
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany. · Pubmed 24619848
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 54 total) written by Kenneth Marek about Parkinson Disease:

  • Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort. 2018
  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. 2017
  • Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective. 2017
  • Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply. 2017
  • Cognition and the course of prodromal Parkinson's disease. 2017
  • Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. 2017
  • Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. 2017
  • Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease. 2017
  • Portable objective assessment of upper extremity motor function in Parkinson's disease. 2017
  • A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease. 2017
Show List of Full Article Records
Google Searches

Learn more about Kenneth Marek using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in New Haven
Yale University
Miscellaneous institutions in Tubingen
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in New Haven
2018
  • Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA. · University of Pennsylvania School of Medicine and the Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel, University Medical Center Goettingen, Kassel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of California San Francisco, San Francisco, California, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of Rochester Medical Center, Rochester, New York, USA. · University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · Pubmed 28986467
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • a Parkinson's Disease and Movement Disorders Center of Boca Raton , FL , USA. · b Saint Luke's Marion Bloch Neuroscience Institute , Kansas City , MO , USA. · c Hackensack University Medical Center, Movement Disorders Center , Hackensack , NJ , USA. · d Irvine Health Movement Disorders Program , University of California , Irvine , CA , USA. · e Thomas Jefferson University, Sidney Kimmel Medical College , Philadelphia , PA , USA. · f University of Southern California Keck School of Medicine , Los Angeles , CA , USA. · g Institute for Neurodegenerative Disorders , New Haven , CT , USA. · h University of Kansas Medical Center , Kansas City , KS , USA. · Pubmed 27813429
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Pubmed 29114721
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 29063713
  • From the Department of Neurology (B.M.), University Medical Center, Göttingen · Paracelsus-Elena-Klinik (B.M.), Kassel, Germany · Department of Biostatistics (C.J.C.-G., C.S.C.), College of Public Health, University of Iowa, Iowa City · BioLegend Inc. (P.T.), San Diego, CA · Department of Pathology & Laboratory Medicine (L.M.S., J.Q.T.), Center for Neurodegenerative Disease Research, Institute on Aging (L.M.S. , J.Q.T.), and Morris K. Udall Center of Excellence for Parkinson's Disease Research (J.Q.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia · Molecular Genetics Section (A.S.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD · The Michael J. Fox Foundation for Parkinson's Research (M.F.), New York, NY · Institute for Neurodegenerative Disorders (K.M.), New Haven, CT · and Department of Neurosciences (D.G.), University of California, San Diego. · Pubmed 29030452
  • Parkinson's Disease Research, Education, and Clinical Center (PADRECC), Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Parkinson's Associated Risk Study, New Haven, Connecticut, USA. · Eli Lilly and Company, New York, New York, USA. · Pubmed 28906025
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA; Department of Neurology, Oregon Health & Science University, Portland, USA. · Biomedical Signal Processing Laboratory, Portland State University, Portland, OR, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Eli Lilly and Company, New York, NY, USA. · Pubmed 28747279
  • GNS Healthcare, Cambridge, Massachusetts, United States of America. · Novartis, Cambridge, Massachusetts, United States of America. · Alexion Pharmaceuticals, Cambridge, Massachusetts, United States of America. · University of Rochester, Rochester, New York, United States of America. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States of America. · Georgetown University, Washington, DC, United States of America. · National Institute on Aging, NIH, Bethesda, Maryland, United States of America. · University of San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America. · Biogen Idec, Cambridge, Massachusetts, United States of America. · Voyager Therapeutics, Cambridge, Massachusetts, United States of America. · Pubmed 28604798
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York. · Pubmed 28595287
  • Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Neurology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, The University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain. · Department of Neurology, Hephata-Klinik, Hephata Hessisches Diakoniezentrum, e.V., Schwalmstadt-Treysa, Germany. · Cleveland Clinic Neurological Institute, Cleveland, Ohio, USA. · Division of Neurology, McGill University, Montreal, Québec, Canada. · Department of Neurology, Philipps University, Marburg, Germany. · Charitable Hertie Foundation, Frankfurt, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28554959
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, People's Republic of China. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 27666574
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Catalonia, Spain. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · BioLegend Inc, Dedham, Massachusetts, USA. · Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Department of Neurology, St. Olav's Hospital, Trondheim, Norway. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada. · Biostatistics and Data Management Core Facility, IDIBAPS (Hospital Clinic), Barcelona, Spain. · Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Centro en Red para la Investigación de Enfermedades Neurodegenerativas CIBERNED, Spain. · Pubmed 27041685
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Department of Pharmacology, Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Republic of Korea. · Paracelsus-Elena Klinik, Kassel, Germany. · Department of Neuropathology and Neurosurgery, University Medical Center Goettingen, Göttingen, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Veterans Affairs, Philadelphia, PA, USA. · Department of Neurosciences, University of California, San Diego, CA, USA. · BioLegend Inc., Dedham, MA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · University of California-San Francisco and San Francisco Veteran's Affairs Medical Center, San Francisco, CA, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Laboratory of Neuro Imaging, The Institute for Neuroimaging and Informatics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 27021906
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, University of Rochester School of Medicine, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 26293177
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2015
  • Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, China. · Hopital De La Salpetriere, Paris, France. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-FIMA, Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474317
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · University of Navarra-FIMA, Pamplona, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474316
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Veteran Affairs Medical Center, San Francisco, California, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular Neuroimaging, LLC (MNI), New Haven, Connecticut, USA. · Baylor College of Medicine, Houston, Texas, USA. · Department of Neurology, University of California, San Francisco, CA, USA. · Emory University, Atlanta, Georgia, USA. · University of Tuebingen, Tuebingen, Germany. · Innsbruck Medical University, Innsbruck, Austria. · Paracelsus-Elena Klinik, Kassel, Germany. · Johns Hopkins University, Baltimore, Maryland, USA. · Macquarie University, Sydney, Australia. · Pubmed 26260437
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · The University of Iowa, Iowa City, IA, USA. · The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Charitable Hertie Foundation, Frankfurt/Main, Germany. · Hephata-Klinik, Hephata Hessisches Diakoniezentrum e. V. · Innsbruck Medical University, Innsbruck, Austria. · McGill University, Montréal, Québec, Canada. · Massachusetts General Hospital, Boston, MA, USA. · UAB School of Medicine, Birmingham, AL, USA. · Pubmed 26095202
2014
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA. · Program for Regulatory Science & Medicine (PRSM), Georgetown University, Washington, D.C., USA. · Pubmed 25062961
  • From the Institute for Neurodegenerative Disorders (D.J., J.S., K.M.), New Haven, CT · Parkinson's Disease and Movement Disorders Center (M.S.), Department of Neurology, University of Pennsylvania, Philadelphia · Department of Biostatistics and Computational Biology (S.E., D.O.), University of Rochester, NY · and Avid Radiopharmaceuticals (A.S.), Philadelphia, PA. · Pubmed 25298306
2009
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 19221310
2008
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 19127587
2012
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 23026362
  • Institute for Neurodegenerative Disorders, Molecular NeuroImaging, LLC, New Haven, Connecticut 06510, USA. · Pubmed 22460156
Yale University
2017
  • Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Department of Biostatistics, University of Iowa, 145 N. Riverside Drive, 100 CPHB, Iowa City, Iowa, 52242, USA. · BioLegend, Inc., 180 Rustcraft Rd # 140, Dedham, Massachusetts, 02026, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Kassel, Germany. · Georg-August University Medical Center Goettingen, 37075, Goettingen, Germany. · Program in Neuroscience and Division of Neurology, The Ottawa Hospital, University of Ottawa Brain & Mind Institute, 451 Smyth Road, Room 1412, Ottawa, K1H 8M5, Canada. · Follow the Molecule, 143 Voyage Mall, Marina del Rey, CA, 90292, USA. · PAREXEL International, Early Phase Unit, 1560 E. Chevy Chase Drive, Suite 140, Glendale, CA, 91206, USA. · Research Programs, The Michael J. Fox Foundation for Parkinson's Research, 69 7th Avenue, 498, New York, NY, 10018, USA. · Yale-New Haven Hospital, 20 York Street, New Haven, CT, 06510, USA. · Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. · Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Pubmed 28821274
2012
  • Yale University School of Medicine, New Haven, Connecticut 06519, USA. · Pubmed 22609082
Miscellaneous institutions in Tubingen
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2014
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany. · Pubmed 24619848
Unspecified
2016
  • Northwestern University Feinberg School of Medicine, United States. Electronic address: · The University of Iowa, United States. Electronic address: · The University of Iowa, United States. Electronic address: · Institute for Neurodegenerative Disorders, United States. Electronic address: · University of California San Francisco, United States. Electronic address: · Institute for Neurodegenerative Disorders, United States. Electronic address: · Pubmed 27132498
Georgetown University
2015
  • 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · 3 Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 6 Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. · 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · 8 Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC 20007, USA. · 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 9 Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA. · 10 Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario K1H8M5, Canada. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA · Pubmed 26220939
Miscellaneous cities in Connecticut
2015
  • 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. · 2 Institute for Neurodegenerative Disorders, 60 Temple Street, Connecticut 06510, USA. · 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark. · 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark. · 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark · Pubmed 26209314
University of Rochester
2014
  • From the Institute for Neurodegenerative Disorders (K.M., J.S., D.J.), University of Rochester (S.E., D.O.), Rochester, NY · Georgetown University (I.S.), Washington, DC · University of Toronto (A.E.L.) · and Western University (C.H.), London, Ontario, Canada. · Pubmed 24759846
2009
  • Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. · Pubmed 19691116
2008
9 Other Locations Show
Yearly article counts 0112695562134
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.